Clinical Trial Update: Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing enamel matrix derivatives together with autogenous bone graft for intrabony periodontal defects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontal Disease
• Periodontitis

Drugs mentioned

• Autogenous bone graft (bone graft)
• Emdogain (Enamel Matrix Derivative)

Snippet

Sponsor: Haner Direskeneli, Prof | Conditions: Periodontal Bone Loss, Chronic Periodontitis | Phase 4 | Status: COMPLETED